AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Xu Y, Zhang X, Zhang R, Sun Y, et al. Cancer Lett 2023;566:216240.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Y, Zhang X, Zhang R, Sun Y, et al. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Cancer Lett 2023;566:216240.
PMID: 37217071